Head-to-Head Comparison of [18F]PSMA-1007 and [18F] FDG PET/CT in Patients with Triple-Negative Breast Cancer

被引：0
|
作者：
Andryszak, N. [1 ,2 ]
Swiniuch, D. [3 ]
Wojcik, E. [4 ]
Ramlau, R. [3 ]
Ruchala, M. [1 ]
Czepczynski, R. [1 ,2 ]
机构：
[1] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland
[2] Affidea, Dept Nucl Med, Poznan, Poland
[3] Poznan Univ Med Sci, Dept Oncol, Poznan, Poland
[4] Dept Oncol Med Ctr HCP, Poznan, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-037
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [41] Comparison of PSMA Immunohistochemistry Scoring Systems to Parametric [18F]PSMA-1007 PET/MRI in Primary Prostate Cancer
    Bidakhvidi, N. Ahmadi
    Gevaert, T.
    De Schepper, M.
    Baldewijns, M.
    Havinga, E.
    Deckers, W.
    Laenen, A.
    Devos, G.
    Giesen, A.
    Joniau, S.
    Koole, M.
    Everaerts, W.
    Deroose, C. M.
    Goffin, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S542 - S543
  • [42] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Chikatamarla, Venkata Avinash
    Okano, Satomi
    Jenvey, Peter
    Ansaldo, Alexander
    Roberts, Matthew J.
    Ramsay, Stuart C.
    Thomas, Paul A.
    Pattison, David A.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [43] [18F]PSMA-1007 PET/CT findings in patient with the third oligometastatic brain recurrence of prostate cancer
    Khalimon, A.
    Antonevskaya, T.
    Atakishieva, L.
    Khodzhibekova, M.
    Leontyev, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S866 - S866
  • [44] Head to head comparison of [18F]SiTATE versus [18F]DOPA-PET in patients with neuroendocrine tumors
    Roll, W.
    Hadjitheodorou, P.
    Alevroudis, E.
    Kyrou, K.
    Adamou, G.
    Fesas, A.
    Pourkhessalian, M. R.
    Kalogirou, C.
    Tsechelidis, I.
    Schafers, M.
    Vrachimis, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S514 - S515
  • [45] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Venkata Avinash Chikatamarla
    Satomi Okano
    Peter Jenvey
    Alexander Ansaldo
    Matthew J. Roberts
    Stuart C. Ramsay
    Paul A. Thomas
    David A. Pattison
    EJNMMI Research, 11
  • [46] The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer, A Scoping Review
    Armany, David
    Vo, Lequang
    Self, Duncan
    Baskaranathan, Sriskanthan
    Hossack, Tania
    Bariol, Simon
    Ende, David
    Woo, Henry Hyunshik
    CANCERS, 2025, 17 (06)
  • [47] The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer
    Albano, Domenico
    Temponi, Alessandro
    Bertagna, Francesco
    Suardi, Nazareno
    Talin, Anna
    Bonu, Marco Lorenzo
    Triggiani, Luca
    ANNALS OF NUCLEAR MEDICINE, 2025,
  • [48] Head-to-head comparison of rCBF derived from dynamic [18F]florbetapir and [18F]flortaucipir PET studies in SCD subjects
    Tuncel, H.
    Visser, D.
    Timmers, T.
    Wolters, E.
    Ossenkoppele, R.
    van De Flier, W.
    van Berckel, B.
    Boellaard, R.
    Golla, S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 170 - 171
  • [49] Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
    Marinescu, Ioana M.
    Spohn, Simon K. B.
    Kiefer, Selina
    Bronsert, Peter
    Ceci, Lara
    Holzschuh, Julius
    Sigle, August
    Jilg, Cordula A.
    Ruehle, Alexander
    Sprave, Tanja
    Nicolay, Nils H.
    Winzer, Robert
    Rehm, Jana
    Kotzerke, Joerg
    Hoelscher, Tobias
    Grosu, Anca L.
    Ruf, Juri
    Benndorf, Matthias
    Zamboglou, Constantinos
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
    Piron, Sarah
    Verhoeven, Jeroen
    Courtyn, Jan
    Kersemans, Ken
    Descamps, Benedicte
    Pieters, Leen
    Vral, Anne
    Vanhove, Christian
    De Vos, Filip
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345